BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34042227)

  • 1. Propranolol for infantile hemangiomas with hyperinsulinemic hypoglycemia.
    Miyazaki T; Ozeki M; Sasai H; Ohnishi H
    Pediatr Int; 2021 Jun; 63(6):724-725. PubMed ID: 34042227
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple pulmonary infantile hemangiomas responsive to oral propranolol.
    Galdeano F; Herón A; Moreno S; Aprea G; Meneses M; Torrelo A
    Pediatr Dermatol; 2021 Jan; 38(1):226-228. PubMed ID: 33155718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol.
    Colmenero Sendra M; Del Boz González J; Segura Palacios JM; Valladares Millán I; Eguiluz Solana M; de Troya Martín M
    Actas Dermosifiliogr; 2024 Feb; 115(2):215-217. PubMed ID: 37356545
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic infantile hemangiomas treated with oral propranolol--a case series.
    Mhanna A; Franklin WH; Mancini AJ
    Pediatr Dermatol; 2011; 28(1):39-45. PubMed ID: 21261702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol for the treatment of ulcerated infantile hemangiomas: A prospective study.
    Ji Y; Yang K; Zhou J; Zhang X; Xiang B; Jiang X; Xu X; Qiu T; Dai S; Kong F; Lu G; Qiu Q; Zhang Y; Chen S
    J Am Acad Dermatol; 2022 May; 86(5):1149-1151. PubMed ID: 33895205
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient Perspectives: Propranolol for infantile hemangiomas.
    Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
    [No Abstract]   [Full Text] [Related]  

  • 7. Thirty-two Japanese cases of infantile hemangiomas treated with oral propranolol.
    Kagami S; Kaneko M; Katori T
    J Dermatol; 2018 Jun; 45(6):719-722. PubMed ID: 29603774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary experiences in treating infantile hemangioma with propranolol.
    Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
    Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of systemic propranolol treatment on the physical development of pediatric patients with infantile hemangiomas.
    Dong J; Rong H; Dong Z; Chen A; Wang T; Liu S
    Int J Dermatol; 2023 Mar; 62(3):e137-e138. PubMed ID: 35949165
    [No Abstract]   [Full Text] [Related]  

  • 10. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
    Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
    J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.
    Meyer-Mueller C; Nicholson C; Polcari I; Boull C; Maguiness S
    Pediatr Dermatol; 2022 Mar; 39(2):255-259. PubMed ID: 35178750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol for treatment of ulcerated infantile hemangiomas.
    Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
    J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol Use for Infantile Hemangiomas.
    Ryan J
    Plast Surg Nurs; 2015; 35(3):129-30. PubMed ID: 26313676
    [No Abstract]   [Full Text] [Related]  

  • 14. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
    Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
    J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol is more effective than pulsed dye laser and cryosurgery for infantile hemangiomas.
    Kagami S; Kuwano Y; Shibata S; Uwajima Y; Yamada D; Miyamoto A; Miyagawa T; Araki M; Takahashi K; Isomura S; Aozasa N; Masui Y; Yamamoto M; Inuzuka R; Katori T; Sato S
    Eur J Pediatr; 2013 Nov; 172(11):1521-6. PubMed ID: 23812512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful management of airway hemangioma with propranolol.
    Mendiratta V; Varghese B; Chander R; Parakh A; Solanki RS
    Int J Dermatol; 2013 Jun; 52(6):750-2. PubMed ID: 23679882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Infantile hepatic hemangiomas: first-line propranolol monotherapy as new treatment strategy?].
    Baranowski S; Winkler A; Kunzi-Rapp K; Schaal M; Hempel S; Debatin KM; Posovszky C
    Klin Padiatr; 2012 Oct; 224(6):393-5. PubMed ID: 23143767
    [No Abstract]   [Full Text] [Related]  

  • 18. Propranolol-resistant infantile hemangioma successfully treated with sirolimus.
    Dávila-Osorio VL; Iznardo H; Roé E; Puig L; Baselga E
    Pediatr Dermatol; 2020 Jul; 37(4):684-686. PubMed ID: 32323340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-blockers in the treatment of periocular infantile hemangioma.
    Al-Haddad C; El Salloukh NA; El Moussawi Z
    Curr Opin Ophthalmol; 2019 Sep; 30(5):319-325. PubMed ID: 31394556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rare complication - skin atrophy - after systemic conservative therapy of infantile hemangioma.
    Chakhunashvili K; Kvirkvelia E; Todua N; Chakhunashvili DG
    BMC Pediatr; 2024 Feb; 24(1):138. PubMed ID: 38395819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.